
     RDKit          3D

 11 12  0  0  0  0  0  0  0  0999 V2000
   -0.6250    1.8833    0.6191 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6993    1.8702    0.0062 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.4294    0.6950   -0.0627 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4236    0.6980    0.0576 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6883   -0.4727    0.0790 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6912   -0.4980    0.5632 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.1984   -1.8783    0.1779 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0785   -2.7219    0.1403 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.1349   -1.7623   -0.3937 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5949    0.7737   -0.2978 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5796    0.6720   -0.4856 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  4  1  0
  2  3  1  0
  3  6  1  0
  3 11  2  0
  4 10  2  0
  5  4  1  0
  5  6  1  0
  6  7  1  6
  7  8  1  0
  8  9  1  0
  9  5  1  0
M  END
>  <DRUGBANK_ID>  (1) 
DB04541

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
EXPT01592

>  <COMMON_NAME>  (1) 
Cyclo(prolylglycyl)

>  <CAS_NUMBER>  (1) 
97011-16-0

>  <UNII>  (1) 
W7O69J5F2B

>  <SYNONYMS>  (1) 
(S)-Hexahydropyrrolo(1,2-a)pyrazine-1,4-dione-4-17O; Cyclo(pro-gly); Cyclo(pro-O-gly)

$$$$
